Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Association between Platelet/Lymphocyte Ratio and Coronary Artery Disease Severity in Asymptomatic Low Ejection Fraction Patients

  • Ucar, Fatih Mehmet (Department of Cardiology, Trakya University Hospital) ;
  • Acar, Burak (Turkiye Yuksek Ihtisas Training and Research Hospital) ;
  • Gul, Murat (Turkiye Yuksek Ihtisas Training and Research Hospital) ;
  • Ozeke, Ozcan (Turkiye Yuksek Ihtisas Training and Research Hospital) ;
  • Aydogdu, Sinan (Turkiye Yuksek Ihtisas Training and Research Hospital)
  • Received : 2016.02.15
  • Accepted : 2016.04.12
  • Published : 2016.11.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Coronary angiography (CAG) is generally needed in the setting of systolic heart failure (HF) with an unidentified etiology as a part of diagnostic strategy. On the other hand, the clinical value of this invasive strategy is largely unknown. Platelet-lymphocyte ratio (PLR) has recently emerged as a novel inflammatory index that may serve as an important predictor of inflammatory state and overall mortality. The present study aimed to search the predictive value of PLR in determining the extent of coronary atherosclerosis in asymptomatic low ejection fraction (EF) patients. Subjects and Methods: 156 asymptomatic heart failure (HF) subjects (without angina or HF symptoms, mean age: 58 years; to male: 71.2%) were enrolled, and thereafter a CAG was performed. Gensini Score was used to determine the severity of coronary artery disease (CAD) on CAG. According to this scoring system, the overall study group was categorized into three distinct subgroups: control group with the score 0, mild atherosclerosis group with the score 0 to 20 and severe atherosclerosis group with the score of >20. Thereafter, a comparison was made among groups with regard to mean values of PLR. Results: The severe atherosclerosis group had a substantially higher level of mean PLR in comparison to other groups (p<0.001). Pre-CAG PLR levels as well as a variety of clinical variables including age, low density lipoprotein (LDL)-cholesterol demonstrated an independent correlation with Gensini score through a multivariate analysis. Conclusion: These findings suggest the potential association of high PLR levels with severe atherosclerosis in the setting of asymptomatic systolic HF. A simple measurement of PLR helps to identify the severity of coronary atherosclerosis prior to conducting coronary angiography.

Keywords

References

  1. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69. https://doi.org/10.1093/eurjhf/hfs105
  2. Bart BA, Shaw LK, McCants CB Jr, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-8. https://doi.org/10.1016/S0735-1097(97)00235-0
  3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95. https://doi.org/10.1056/NEJMra043430
  4. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006;97:993-6. https://doi.org/10.1016/j.amjcard.2005.10.034
  5. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653-7. https://doi.org/10.1016/j.amjcard.2008.05.006
  6. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94. https://doi.org/10.1056/NEJMra071014
  7. Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology 2016;67:336-45. https://doi.org/10.1177/0003319715591751
  8. Gary T, Pichler M, Belaj K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013;8:e67688. https://doi.org/10.1371/journal.pone.0067688
  9. Yuksel M, Yildiz A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2015;15:640-7. https://doi.org/10.5152/akd.2014.5565
  10. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. https://doi.org/10.1016/S0002-9149(83)80105-2
  11. American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/ SCMR 2011 Appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 2011;24:229-67. https://doi.org/10.1016/j.echo.2010.12.008
  12. Melo RM, Melo EF, Biselli B, Souza GE, Bocchi EA. Clinical usefulness of coronary angiography in patients with left ventricular dysfunction. Arq Bras Cardiol 2012;98:437-41. https://doi.org/10.1590/S0066-782X2012005000035
  13. ten Kate GJ, Caliskan K, Dedic A, et al. Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology. Eur J Heart Fail 2013;15:1028-34. https://doi.org/10.1093/eurjhf/hft090
  14. Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol 2000;86:449-51. https://doi.org/10.1016/S0002-9149(00)00963-2
  15. Iijima R, Ndrepepa G, Mehilli J, et al. Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost 2007;98:852-7. https://doi.org/10.1160/TH07-04-0285
  16. Nikolsky E, Grines CL, Cox DA, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007;99:1055-61. https://doi.org/10.1016/j.amjcard.2006.11.066
  17. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-7. https://doi.org/10.1161/01.CIR.84.2.613
  18. Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326-34. https://doi.org/10.1007/s11239-012-0718-6
  19. Yildiz A, Yuksel M, Oylumlu M, et al. The utility of the plateletlymphocyte ratio for predicting no reflow in patients with STsegment elevation myocardial infarction. Clin Appl Thromb Hemost 2015;21:223-8. https://doi.org/10.1177/1076029613519851
  20. Açar G, Kalkan ME, Avci A, et al. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost 2015;21:462-8. https://doi.org/10.1177/1076029613508599
  21. Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophil to lymphocyte and platelet to lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol 2015;73:1310-6. https://doi.org/10.5603/KP.a2015.0098
  22. Stancel N, Chen CC, Ke LY, et al. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Clin Chem 2016;62:320-7. https://doi.org/10.1373/clinchem.2015.243923
  23. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-7. https://doi.org/10.1073/pnas.92.9.3893

Cited by

  1. Retinal and choroidal vascular changes in coronary heart disease: an optical coherence tomography angiography study vol.10, pp.4, 2016, https://doi.org/10.1364/boe.10.001532
  2. Biomarkers of nondipper hypertension in prehypertensive and hypertensive patients vol.13, pp.5, 2016, https://doi.org/10.2217/bmm-2018-0247
  3. Association of Platelet Integrin αIIbβ3 Polymorphisms with Atherosclerotic Coronary Heart Disease in Sudanese Patients vol.22, pp.7, 2019, https://doi.org/10.3923/pjbs.2019.335.341
  4. Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review vol.70, pp.9, 2016, https://doi.org/10.1177/0003319719845186
  5. The correlation between novel peripheral blood cell ratios and 90-day mortality in patients with acute ischemic stroke vol.15, pp.8, 2016, https://doi.org/10.1371/journal.pone.0238312
  6. Relationship Between Platelet to Lymphocyte Ratio and Stable Coronary Artery Disease: Meta-Analysis of Observational Studies vol.71, pp.10, 2016, https://doi.org/10.1177/0003319720943810
  7. The Significance of Platelet/Lymphocyte Ratio in Relation to Coronary Angiographic Findings in Patients with Coronary Artery Disease vol.3, pp.1, 2016, https://doi.org/10.1007/s42399-020-00692-4
  8. Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients vol.55, pp.4, 2016, https://doi.org/10.1080/14017431.2021.1900595
  9. The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study vol.8, pp.4, 2016, https://doi.org/10.1002/ehf2.13390